Spago Nanomedical begins endometriosis study by FMR Global | Dec 15, 2022 | FMR GLOBAL | 0 comments Clinical trial has received regulatory approval and involves endometriosis candidate SN132D Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
